Gadsden Properties (OTCMKTS:GADS) versus Electromed (NYSE:ELMD) Head to Head Analysis

Electromed (NYSE:ELMDGet Free Report) and Gadsden Properties (OTCMKTS:GADSGet Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings.

Volatility & Risk

Electromed has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Comparatively, Gadsden Properties has a beta of -7.36, meaning that its share price is 836% less volatile than the S&P 500.

Insider and Institutional Ownership

40.8% of Electromed shares are held by institutional investors. 14.0% of Electromed shares are held by company insiders. Comparatively, 5.0% of Gadsden Properties shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Electromed and Gadsden Properties’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Electromed 11.34% 15.71% 13.37%
Gadsden Properties N/A N/A N/A

Valuation and Earnings

This table compares Electromed and Gadsden Properties”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Electromed $61.44 million 2.90 $5.15 million $0.79 26.88
Gadsden Properties N/A N/A N/A N/A N/A

Electromed has higher revenue and earnings than Gadsden Properties.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Electromed and Gadsden Properties, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed 0 0 0 1 4.00
Gadsden Properties 0 0 0 0 0.00

Electromed currently has a consensus target price of $38.00, indicating a potential upside of 78.98%. Given Electromed’s stronger consensus rating and higher probable upside, equities analysts plainly believe Electromed is more favorable than Gadsden Properties.

Summary

Electromed beats Gadsden Properties on 10 of the 10 factors compared between the two stocks.

About Electromed

(Get Free Report)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

About Gadsden Properties

(Get Free Report)

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.